NasdaqGS - Nasdaq Real Time Price USD

Performant Healthcare, Inc. (PHLT)

2.7000
-0.0300
(-1.10%)
As of 10:04:58 AM EDT. Market Open.
Loading Chart for PHLT
  • Previous Close 2.7300
  • Open 2.6600
  • Bid 2.5900 x 100
  • Ask 2.7700 x 100
  • Day's Range 2.6600 - 2.7000
  • 52 Week Range 2.1700 - 4.3500
  • Volume 7,010
  • Avg. Volume 154,368
  • Market Cap (intraday) 211.433M
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.00

Performant Healthcare, Inc. provides audit, recovery, and analytics services in the United States. It supports healthcare payers in identifying, preventing, and recovering waste and improper payments through advanced technology, analytics, and proprietary data assets. The company also offers coordination-of-benefits services, as well as claims-based services, which includes the audit and identification of improperly paid claims. Further, it provides advanced reporting capabilities, support services, customer care, and stakeholder training programs to mitigate future instances of improper payments. The company was formerly known as Performant Financial Corporation and changed its name to Performant Healthcare, Inc. in December 2024. Performant Healthcare, Inc. was founded in 1976 and is headquartered in Plantation, Florida.

performantcorp.com

964

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PHLT

View More

Performance Overview: PHLT

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PHLT
10.60%
S&P 500 (^GSPC)
1.54%

1-Year Return

PHLT
12.05%
S&P 500 (^GSPC)
9.93%

3-Year Return

PHLT
22.73%
S&P 500 (^GSPC)
45.73%

5-Year Return

PHLT
275.00%
S&P 500 (^GSPC)
95.95%

Compare To: PHLT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PHLT

View More

Valuation Measures

Annual
As of 5/22/2025
  • Market Cap

    213.78M

  • Enterprise Value

    212.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.65

  • Price/Book (mrq)

    2.74

  • Enterprise Value/Revenue

    1.65

  • Enterprise Value/EBITDA

    109.35

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.62%

  • Return on Assets (ttm)

    -3.32%

  • Return on Equity (ttm)

    -7.65%

  • Revenue (ttm)

    128.92M

  • Net Income Avi to Common (ttm)

    -5.96M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.98M

  • Total Debt/Equity (mrq)

    11.37%

  • Levered Free Cash Flow (ttm)

    7.36M

Research Analysis: PHLT

View More

Company Insights: PHLT

Research Reports: PHLT

View More

People Also Watch